Abstract
The abdominal wall is the location of a wide spectrum of pathological conditions, from benign to malignant ones. Imaging is often recommended for the evaluation of known palpable abdominal masses. However, abdominal wall pathologies are often incidentally discovered and represent a clinical and diagnostic challenge. Knowledge of the possible etiologies and complications, combined with clinical history and laboratory findings, is crucial for the correct management of these conditions. Specific imaging clues can help the radiologist narrow the differential diagnosis and distinguish between malignant and benign processes. In this pictorial review, we will focus on the non-neoplastic benign masses and processes that can be encountered on the abdominal wall on cross-sectional imaging, with a particular focus on their management. Distinctive sonographic imaging clues, compared with computed tomography (CT) and magnetic resonance (MR) findings will be highlighted, together with clinical and practical tips for reaching the diagnosis and guiding patient management, to provide a complete diagnostic guide for the radiologist.
Keywords: abdominal wall, incidentalomas, diagnosis, differential, ultrasonography, computed tomography, magnetic resonance imaging
1. Introduction
Benign abdominal wall lesions comprise a wide spectrum of conditions, including benign masses, tumors, and mimickers of neoplastic conditions. Abdominal wall masses generally present as unexpected incidental findings during radiological examinations performed for other clinical reasons, most commonly during computed tomography (CT), and therefore usually represent a clinical dilemma. In many cases, the likely diagnosis can be reached by combining clinical history (i.e., prior therapies, oncologic history, recent surgery, or trauma) and imaging features [1]. However, some lesions still need to undergo a biopsy for the final diagnosis to be made.
Ultrasonography (US) is commonly the first-line exam performed for palpable superficial lesions, providing information on echogenicity, gross vascularization, relationships with nearby vessels, and elasticity. US is also usually used to guide interventional procedures and biopsies. Computed tomography (CT) provides anatomical information on mass extension and involvement of deeper abdominal wall structures, and it is usually preferred in emergency settings or abdominal traumas. Magnetic resonance (MR) is a second-line examination that helps understand the content and nature of a mass and is also useful in selected cases of benign non-neoplastic diseases that require further diagnostic assessment, such as endometriosis [2].
The differential diagnosis among abdominal wall masses can be performed by adopting a clinical–radiologic flowchart. The diagnostic flowchart first includes the differentiation between a mass and a mass-like process. Then, the internal composition of the mass should be determined (e.g., fat, fluid, solid, or fibrous). Then, according to the main components, laboratory results, and clinical history, a differential diagnosis should be made. Based on the origin, abdominal non-neoplastic diseases include infectious processes (e.g., abscesses, necrotizing fasciitis, granulomas, gossypibomas, and fistulae), congenital conditions (e.g., urachal anomalies, defects of the abdominal wall, manifestations of muscular dystrophies, arteriovenous malformations), acquired vascular conditions (e.g., shunts, pseudoaneurysm, and hematomas), and storing and miscellaneous diseases (e.g., injection granulomas from silicone, paraffin, or other drugs; calcinosis; collagen diseases; splenosis; and endometriosis) [1,2,3,4].
This pictorial review aims to depict the spectrum of benign non-neoplastic diseases that may be encountered in the abdominal wall, providing tips for differential diagnosis and their management. For each case, key imaging aspects will be highlighted, drawing a diagnostic guide for the radiologist.
2. Infective Pathologies
Infective conditions present as recently appearing lesions accompanied by clinical signs suggestive of inflammation and infections, such as fever, increase in white blood count or C-reactive protein, and redness. Surgical history has an important role, as does the presence of risk factors such as immunocompromised statuses or open wounds [3].
2.1. Abscess
Abdominal wall abscesses can manifest as an extension of intra-abdominal processes or as primary infections [4,5,6,7]. Risk factors include surgery, hematomas, diverticulitis, cholecystitis, appendicitis [7], and Crohn’s disease [5].
Abdominal wall abscesses present on US as superficial fluid-filled complex lesions, with ill-defined margins, predominantly hypoechoic to surrounding muscles [7,8]. Peripheral hyperemia can be seen on Color Doppler US (CDUS) [3] (Figure 1). To define the extent of the abscess, contrast-enhanced CT and MR could be used in severe cases.
Over time, an abscess becomes walled off by vascularized connective tissue, which corresponds to an enhancing rim, best seen on the venous phase [9]. The enhancing rim surrounds a central low-density necrotic area [6] that contains small air bubbles, suggestive of bacterial degeneration in around 60% of cases [3]. On MR, abscesses show homogeneously high T2 signal in early phases, which later becomes heterogeneous, as the amount of necrosis, gas, and proteinaceous debris increases [9]. Subcutaneous abscesses are important to recognize to avoid systemic evolution and commonly require drainage, along with antibiotics [7]. Percutaneous drainage can be performed by open incision or under ultrasound or CT guidance, according to the location.
2.2. Necrotizing Fasciitis
Necrotizing fasciitis (NF) is a soft tissue necrotic infection that involves the fascia and subcutaneous tissue [10]. If not promptly diagnosed, NF may rapidly lead to sepsis and multiple organ failure (MOF) [11], with a mortality of 70–80% [10,11,12,13]. Risk factors include intravenous drug use, diabetes mellitus, immunosuppression, obesity, and peripheral vascular diseases.
On CT, the most suggestive findings of NF are the thickening of the fascia and a large amount of subcutaneous gas, although the latter is not specific [10,11,12] (Figure 2).
Focal or diffuse non-enhancing areas [10,11] with extensive multi-compartmental involvement (meaning that at least three muscle compartments are involved in this change) are another typical finding.
On MR, high-signal-intensity areas may be observed on T2-weighted sequences, representing necrosis and edema, alternated with intralesional gas. On T1-weighted sequences, loss of muscle texture and possible high signal intensity compatible with intramuscular hemorrhage might be seen [10,11]. A necrotizing infection mostly requires urgent and aggressive surgical debridement, together with antibiotic therapy and hemodynamic support as necessary.
2.3. Foreign Body Retention: Granuloma and Gossypiboma
Granulomas are protective responses to destroy or sequester particles that are deemed harmful to the body, frequently seen in the context of chronic infections, inflammatory diseases, and foreign bodies. On US, retained foreign bodies are usually hyperechoic with posterior acoustic shadowing, although their appearance depends on their content [3]. As granulomas develop, they appear as well-defined nodular lesions with a peripheral hyperechoic, ill-defined halo that slowly becomes hypoechoic and then hypervascular [3,8]. CT demonstrates a soft tissue lesion with punctuate or gross calcifications, surrounded by fat stranding [5]. Slight peripheral contrast uptake is seen in chronic stages (Figure 3).
Gossypibomas are secondary to the retention of surgical sponges or gauze. The abdominal wall is a rare localization, but this diagnosis should be suspected in post-surgical patients with recurrent infection, fever, and pain. On CT, abdominal wall gossypibomas are thick-walled collections in the abdominal muscles or subcutaneous fat, with an air-like density center and a small fluid component, sometimes with metallic parts [14].
In both conditions, until the foreign body is surgically removed, the inflammation will continue. If unrecognized, they can evolve into systemic infection and septic shock [15].
2.4. Fistulae
Enterocutaneous abdominal wall fistulae (ECFs) are abnormal connections between a bowel loop and the nearby skin that may be secondary to abdominal surgery or inflammatory bowel diseases. ECFs can either appear collapsed or patent with gaseous or fluid content (“tram-track” appearance) (Figure 4).
Abdominal wall fistulae are seen as hypoechoic or anechoic duct-like structures on US but are better studied on MR or CT, as these latter depict the connection between the bowel loops and the peritoneum or the cutis [16].
Fistulae need to be surgically repaired; otherwise, chronic infections may develop. Abscesses can indeed complicate ECFs: lesions above 2 cm, irregularly large, with thickened walls and patent peripheral sections should raise suspicion for superimposed abscesses [16].
3. Congenital Conditions
3.1. Urachal Anomalies
Urachal anomalies are due to an incomplete obliteration of the urachus, the embryologic communication between the bladder and the umbilicus [17,18]. According to the location of the patency, four types of anomalies should be distinguished: patent urachus, urachal sinus, urachal cyst, and vesicourethral diverticulum [17].
The differential diagnosis includes malignancies, metastases, and endometriosis. Usually diagnosed during childhood, they are commonly studied on US.
In the case of patent urachus, US shows a tubular structure with hypoechoic walls and anechoic content, traced along the anterior abdominal wall [18,19]. Urachal cysts are round midline, homogeneous fluid-filled structures with well-defined walls, located between the bladder and the abdominal muscles, that may contain rim calcifications [17,18,19] (Figure 5).
Umbilical–urachal sinus occurs at the umbilical end of the urachus and is seen as a fusiform outpouching structure into the abdominal wall. Imaging reveals a thickened, fusiform blind dilatation below the navel, with no communication with the bladder. Superinfection can complicate all urachal anomalies, and in that case, peripheral contrast enhancement will be seen [17]. Stone formation can complicate diverticula. Urachal remnants can degenerate into adenocarcinoma, carrying a poor prognosis due to its late presentation. The role of prophylactic surgery in these cases is still highly debated [19].
3.2. Congenital Defects of the Abdominal Wall
The most common congenital defect of the abdominal wall is the absence of transversus abdominis muscle, followed by internal oblique and external oblique absence [20], which might be the aftermath of more serious conditions. For example, in infancy, congenital abdominal wall defects can be part of the “prune belly syndrome”, whose main features are abdominal wall flaccidity, urological abnormalities, and cryptorchidism [21] (Figure 6). Radiologists should report the presence of these defects in patients who have to undergo abdominal surgeries because the surgical approach has to be modified accordingly [20].
Neuromuscular dystrophies can also present defects of the abdominal wall. Duchenne muscular dystrophy is the most common one and is clinically characterized by progressive muscle weakness, starting from the proximal pelvic girdle [22], whose pathognomonic appearance on CT and MR is a progressively extensive fatty replacement of muscles [22,23] (Figure 7).
3.3. Arteriovenous Malformations
Arteriovenous malformations (AVMs) are congenital lesions consisting of a tangle of arteries and veins connected by one or more fistulae [8,24].
It is important to distinguish between isolated and syndromic AVMs (e.g., Rendu–Osler disease, PTEN mutations) [25].
AVMs of the abdominal wall are often unilateral, interdigitated with fat, and adjacent to or within the anterolateral muscle groups [13]. Color Doppler US shows focal anechoic vascular dilatations with heterogeneous vascular flow [24]. Contrast-enhanced CT or MRI is performed to depict the relationship with abdominal vessels. Abdominal wall AVMs are usually non-painful superficial lumps. Depending on the site, size, and symptoms, treatment options vary from conservative management to embolization or surgical resection [24].
4. Acquired Vascular Conditions
4.1. Shunts
Acquired shunts in the abdominal wall might be a sign of portal hypertension or inferior vena cava obstruction, which are both conditions to assess and not underestimate. Indeed, if untreated, the first one may lead to cirrhosis and hepatocellular carcinoma, and the latter can lead to pulmonary embolisms. Acquired shunts are caused by dilatation of the paraumbilical veins within the round ligament [26,27,28].
The paraumbilical veins will connect the superior and inferior epigastric veins in the rectus sheath with the left branch of the portal vein at the umbilicus [29], with an appearance called “caput medusae”.
CT should be preferred, in order to study all of the other signs of portal hypertension [27]. Treatment of shunts is linked to the treatment of the underlying causative condition, although in some cases bleeding can also be seen (Figure 8).
4.2. Pseudoaneurysm
Pseudoaneurysms, or false aneurysms, originate from the disruption of intimal and medial layers of an arterial vessel, after traumas, infections, or iatrogenic procedures [30,31,32]. On US, pseudoaneurysms are anechoic tubular structures, with thin walls [30,31] and turbulent Doppler flow (“yin–yang” appearance).
CT angiography is the gold standard for the diagnosis, as it precisely depicts the vascular structures involved [31] and demonstrates the integrity of the pseudoaneurysm sac (Figure 9), which should be smooth unless an infection superimposes.
All pseudoaneurysms should be regarded as surgical urgencies, as they are considered at risk of rupture and therefore should be promptly treated to avoid bleeding [30]. Treatment includes ultrasound-guided thrombin injections and ultrasound compression, endovascular treatments with stent graft placement, and surgical repair. Among minimally invasive procedures, US-guided thrombin injection is usually preferred as it has a higher success rate compared to US-guided simple compression [33].
4.3. Hematoma
Abdominal wall hematomas are a common—though often misdiagnosed—cause of acute abdominal pain [34,35]. They mostly involve the rectus muscle (“rectus sheath hematoma”, RSH) and less frequently involve lateral and posterior abdominal muscles [13]. To correctly predict the aftermaths of abdominal wall hematomas, it is important to assess their location. The first step is to locate the arcuate line.
Above the arcuate line, RSHs are circumscribed and spindle-shaped (Figure 10); below the arcuate line, there is no anatomical barrier: RSH can cross the midline, and blood can extend into the peritoneum and prevesical space [1,5,13] (Figure 11).
Hematomas are well-defined masses, with higher attenuation than muscles [9] on unenhanced CT and high-T1, low T2 signals on MR in acute phases [9]. When hematomas are seen, active contrast extravasation must always be ruled out on CT [5,35]. As time passes, the hematoma evolves, and its attenuation becomes lower and lower on CT, reaching serum density after 2–4 weeks [1,5,9]. On chronic stages, the MR signal of hematomas becomes layered. On the periphery, the signal will be low on both T1- and T2-weighted sequences, while on the center, the hematoma will be isointense on T1 sequences and high on T2-weighted ones.
The main consequence of undiagnosed or untreated rectus hematomas is pain and bleeding, which can become life-threatening. Severe bleeding should be promptly identified and aggressively treated with urgent arterial embolization or surgical intervention. Another potential complication is abscess formation, as in any blood collection that is not drained [36].
5. Storing and Miscellaneous Diseases
5.1. Injection Granulomas
Injection granulomas may develop as an inflammatory response to repeated injections and lead to localized fat necrosis, scar formation, and dystrophic calcification, simulating malignant diffuse processes [9,10,11,12,13] (Figure 12), and require no particular management.
On CT, granulomas are well-defined small nodules with soft-tissue attenuation, often with peripheral calcifications [13]. MR shows T1 hypointense nodules with mild-to-moderate high T2-w signal, depending on the presence of inflammation or fibrosis [9,13].
5.2. Silicone and Paraffin
Free silicone and paraffin injections are dangerous beauty techniques, disused but still performed illegally [37]. Serious reactions to silicone injections have been reported, occurring 3 weeks to 23 years after treatment. Aftermaths include strong pain, skin lesions, deformities, recurrent cellulitis and abscesses, granulomas (“siliconoma” and “paraffinoma”) in the subcutaneous and muscular tissue, lymphadenopathy, silicone migration, and necrosis [37,38,39]. Systemic complications have also been reported, including acute pneumonitis, granulomatous hepatitis, organ compression, and sudden death secondary to intravascular embolization [40].
Free silicone and paraffin are seen as irregularly scattered collections extended along fascial planes, mimicking sarcomatous or metastatic processes [38,39].
On US, they are heterogeneously echoic, with marked posterior acoustic shadowing [39]. On CT, their diffuse infiltrating appearance is well seen, with solid density but a lack of contrast uptake, accompanied by fat stranding [37,38] (Figure 13).
MR appearance comprises a main, plaque-like, ill-defined lesion with a low-to-intermediate signal on T1- and T2-weighted images, but also marked loss of signal on fat-suppression and dual gradient echo sequences in paraffinomas [39]. Even years after the injections, these substances also show high tracer uptake on FDG and gallium PET/CT, making the differential diagnosis with malignancies challenging [38]. Treatment of silicone granulomas is difficult and often unsuccessful. Modalities include topic and systemic corticosteroids, systemic therapies with etanercept or minocycline, liposuction, lasers, and local resection. However, surgical excision is difficult because migration to distant sites results in incomplete removal or wide excisions [40].
5.3. Subcutaneous Drugs
Lipohypertrophy is a classical sequela of subcutaneous insulin injections. On CT and MR, it is seen as focal subcutaneous soft-tissue masses, with fat proliferation in a symmetric fashion [41] and calcifications [41,42,43]. “Insulin balls” can also occur, subcutaneous amyloid deposits, visible as soft-tissue masses, with necrotic borders, due to amyloid toxicity [43] (Figure 14).
Management is different between these two conditions: while lipohypertrophy disappears with the suspension of insulin therapy, insulin balls tend to progressively enlarge and require surgical excision [42]. Repeated heparin injections can be associated with air and fluid levels [9]; small soft-tissue nodules, connected to the destruction of the hypodermic fat; and small hematomas with adjacent hazy soft tissue [44] (Figure 14). There is no special management, only a recommendation to alternate the injection spot when performing heparin injection.
5.4. Calcinosis and Collagen Diseases
Systemic alterations in calcium metabolism can lead to extensive subcutaneous calcinosis [13], either due to neoplastic (e.g., paraneoplastic syndromes, metastases) or non-neoplastic conditions (e.g., chronic kidney failure, dystrophic calcifications, gout, granulomas, collagen diseases) [44].
Calcinosis Universalis is the main subtype seen in collagen vascular diseases and is recognized on CT as sheet-like deposits of calcifications in the subcutaneous tissue and fascial planes, mostly with intramuscular distribution [13,45] (Figure 15).
Currently, we lack specific guidelines for managing calcinosis cutis in autoimmune connective tissue disorders. An intensification of immunosuppressive therapy was suggested, but no specific treatment was recommended. Rituximab and bisphosphonates have been increasingly used with success in dermatomyositis skin lesions [45]. Surgery, laser, and physical therapies should be considered in extensive calcinosis. However, surgical management can lead to skin necrosis and a limited range of motion [45].
5.5. Splenosis
Splenosis is the heterotopic auto-transplantation of splenic tissue that occurs after a traumatic or surgical rupture of the spleen; it is usually asymptomatic and without any degeneration risk [46]. The abdominal wall is a rare location that may resemble subcutaneous or intramuscular tumors [47,48]; enlarged lymph nodes, hernias, and endometriosis [46]; or peritoneal carcinomatosis [47,48,49].
US appearance is non-specific as it shows round or oval-shaped, hypo- to isoechoic solid masses with posterior acoustic enhancement and an incomplete hyperechoic rim [47]. CT and MR will show round lesions with imaging and contrast behavior similar to the spleen. In doubtful cases, heat-denatured blood cell scintigraphy should be considered [46,47] (Figure 16). Splenosis does not require follow-up or pose a risk for degeneration. Evidence shows that there is no need for surgical excision since it represents normal-functioning splenic tissue [47].
5.6. Endometriosis
Abdominal wall endometriosis (AWE) manifests as solid nodules, with occasional cystic changes due to intralesional bleeding [50]. AWE originates from the embedding of endometrial tissue in the abdominal wall, which develops ventrally and infiltrates the rectus or oblique muscles, appearing as nodular masses known as endometriomas [50,51,52]. The differential diagnosis includes abscess, lipoma, hematoma, sebaceous cysts, granuloma, sarcomas, and desmoid tumors [9]. Consequences vary according to the location, ranging from muscular or nearby organ damage to bleeding.
US demonstrates heterogeneously hypoechoic, round or oval-shaped nodules or masses, with scattered internal echoes, and small cystic areas [9,50,53,54], surrounded by a hyperechoic rim [55] (Figure 17).
CT shows solid masses with ill-defined borders, isoattenuating to the surrounding muscles [55]. After contrast injection, endometriosis may show slight enhancement [50,53,54] and a characteristic “Gorgon sign”, corresponding to linear strands irradiating peripherally from the central nodules [55]. MRI provides excellent contrast resolution and demonstrates the depth of infiltration, gives better tissue definition, and shows the integrity of the surrounding muscle tissue [54]. On MR, abdominal endometriosis is hyperintense on T2-weighted images [50,54,55]; isointense to muscles on T1-weighted sequences, with foci of high signal, suggestive of hemorrhage [50,56]; and presents high signal lesions on fat-saturated T2-weighted images, with moderate enhancement [54,56] (Figure 18). In addition, diffusion-weighted imaging (DWI) may be useful for differentiating AWE from tumors. Regarding endometrial cysts, AWE tends to have lower apparent diffusion coefficient (ADC) values compared with other cysts, due to blood content [50]. However, compared to pelvic endometriosis, while the latter varies from purely cystic chocolate cysts to solid deposits or fibrosis, AWE will show almost invariably a pure solid aspect.
The clinical presentation is heterogeneous. No particular constellation of clinical risk factors has been identified, and the histological report is the major diagnostic tool for confirmation. Imaging including ultrasound and magnetic resonance imaging can assist with the localization of the lesions and aid in surgical excision, which is the first line of therapy [57]. AWE lesions that have been removed in their entirety are unlikely to reoccur [58].
5.7. Abdominal Wall Adhesions
Adhesions at the level of the abdominal wall after surgery may occur in about 39% of patients at risk for adhesions [59]. Indeed, abdominal entry at the time of surgery (e.g., laparoscopy, laparotomy) is a critical step with a risk of injury to underlying viscera owing to bowel adhesions. As the most common laparoscopic point of entry is the umbilical site, many studies investigated abdominal wall adhesions at the periumbilical site demonstrating an approximate bowel adhesion rate of 12% at this level [59]. US allows the assessment of adhesion by investigating the slide of viscera underneath the abdominal wall, with a sensitivity of 91% and specificity of 93% for any site and a sensitivity of 96% and specificity of 93% for the periumbilical site [59]. Abdominal wall adhesions can be more accurately assessed through MRI [60]. MRI studies using cine-MRI to identify abdominal wall adhesions are conducted by running several imaging cycles while instructing the patients to use Valsalva’s maneuver to increase their intra-abdominal pressure and thus provoke the movement of abdominal contents in relation to each other. The lack of visceral slide and separation between organs as well as between organs and the abdominal wall may be interpreted as a sign of adhesion [61]. However, MRI tends to over-diagnose adhesions [60]. The clinical presentation is heterogeneous, from asymptomatic to abdominal distension, pain, nausea, and abnormal bowel movement pattern. The clinical benefit of identification of abdominal wall adhesion after surgery is two-fold: first, patients with abdominal wall adhesions are at increased risk for bowel and mesenteric injury following blunt abdominal trauma and for developing small bowel obstruction; second, knowledge of the location of abdominal wall adhesions allows choosing alternative abdominal entry points for any eventual new surgery in that patient [62,63]. Lysis of abdominal wall adhesions is considered among the therapeutic options [64].
6. Conclusions
The spectrum of benign non-neoplastic abdominal wall diseases is wide. Some benign conditions are easily diagnosed and, in most cases, do not require any further diagnostic workup or follow-up. However, some cases can be challenging, may require further diagnostic assessment, and may need proper urgent treatment or follow-up. Radiologists must be aware of the key imaging features that allow a prompt differential diagnosis among these different diseases, to avoid unnecessary follow-up or overtreatment on one hand and to avoid misdiagnosis or delayed treatment on the other hand. Even though in some cases histology will still be needed to reach the final diagnosis, the role of the radiologist is fundamental to curtail the differential diagnosis and correctly interpret these processes non-invasively.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
Roberto Cannella: support for attending meetings from Bracco and Bayer; co-funding by the European Union—FESR or FSE, PON Research and Innovation 2014–2020—DM 1062/2021. Other authors declare no conflict of interest.
Funding Statement
This research received no external funding.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Vanhoenacker, Filip M., Parizel P.M., Gielen J.L. Imaging of Soft Tissue Tumors. 3rd ed. Springer; Berlin/Heidelberg, Germany: 2017. [Google Scholar]
- 2.van Rijswijk C.S., Geirnaerdt M.J., Hogendoorn P.C., Taminiau A.H., van Coevorden F., Zwinderman A.H., Pope T.L., Bloem J.L. Soft-tissue tumors: Value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology. 2004;233:493–502. doi: 10.1148/radiol.2332031110. [DOI] [PubMed] [Google Scholar]
- 3.Jain N., Goyal N., Mukherjee K., Kamath S. Ultrasound of the abdominal wall: What lies beneath? Clin. Radiol. 2013;68:85–93. doi: 10.1016/j.crad.2012.05.016. [DOI] [PubMed] [Google Scholar]
- 4.Souza A.M.D.E.S., Barbuto T.M., Freitas F.A., Vianna N.F., Zanchetta C.M.C., Forsait S., Borba C., Azambuja A.M.P.D., Cristofani L.M., Odone V. An unusual abdominal wall mass in a child. Rev. Inst. Med. Trop. Sao Paulo. 2017;59:e16. doi: 10.1590/s1678-9946201759016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Virmani V., Sethi V., Fasih N., Ryan J., Kielar A. The abdominal wall lumps and bumps: Cross-sectional imaging spectrum. Can. Assoc. Radiol. J. 2014;65:9–18. doi: 10.1016/j.carj.2012.02.001. [DOI] [PubMed] [Google Scholar]
- 6.Kuwahara K., Mokuno Y., Matsubara H., Kaneko H., Shamoto M., Iyomasa S. Development of an abdominal wall abscess caused by fish bone ingestion: A case report. J. Med. Case Rep. 2019;13:369. doi: 10.1186/s13256-019-2301-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zizzo M., Zaghi C., Manenti A., Luppi D., Ugoletti L., Bonilauri S. Abdominal wall abscess secondary to spontaneous rupture of pyogenic liver abscess. Int. J. Surg. Case Rep. 2016;25:110–113. doi: 10.1016/j.ijscr.2016.06.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bashir U., Moskovic E., Strauss D., Hayes A., Thway K., Pope R., Messiou C. Soft-tissue masses in the abdominal wall. Clin. Radiol. 2014;69:e422–e431. doi: 10.1016/j.crad.2014.06.006. [DOI] [PubMed] [Google Scholar]
- 9.Stein L., Elsayes K.M., Wagner-Bartak N. Subcutaneous Abdominal Wall Masses: Radiological Reasoning. Am. J. Roentgenol. 2012;198:W146–W151. doi: 10.2214/AJR.10.7238. [DOI] [PubMed] [Google Scholar]
- 10.Yoon M.A., Chung H.W., Yeo Y., Yoo H.J., Kang Y., Chee C.G., Lee M.H., Lee S.H., Shin M.J. Distinguishing necrotizing from non-necrotizing fasciitis: A new predictive scoring integrating MRI in the LRINEC score. Eur. Radiol. 2019;29:3414–3423. doi: 10.1007/s00330-019-06103-0. [DOI] [PubMed] [Google Scholar]
- 11.Carbonetti F., Cremona A., Carusi V., Guidi M., Iannicelli E., Di Girolamo M., Sergi D., Clarioni A., Baio G., Antonelli G., et al. The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC) Radiol. Med. 2016;121:106–121. doi: 10.1007/s11547-015-0575-4. [DOI] [PubMed] [Google Scholar]
- 12.Tso D.K., Singh A.K. Necrotizing fasciitis of the lower extremity: Imaging pearls and pitfalls. Br. J. Radiol. 2018;91:20180093. doi: 10.1259/bjr.20180093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ballard D.H., Mazaheri P., Oppenheimer D.C., Lubner M.G., Menias C.O., Pickhardt P.J., Middleton W.D., Mellnick V.M. Imaging of Abdominal Wall Masses, Masslike Lesions, and Diffuse Processes. RadioGraphics. 2020;40:684–706. doi: 10.1148/rg.2020190170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Huston T.L., Grant R.T. Abdominal wall gossypiboma. J. Plast. Reconstr. Aesthet. Surg. 2010;63:e463–e464. doi: 10.1016/j.bjps.2009.07.034. [DOI] [PubMed] [Google Scholar]
- 15.Sozutek A., Colak T., Reyhan E., Turkmenoglu O., Akpınar E. Intra-abdominal Gossypiboma Revisited: Various Clinical Presentations and Treatments of this Potential Complication. Indian J. Surg. 2015;77((Suppl. 3)):1295–1300. doi: 10.1007/s12262-015-1280-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lee J.K., Stein S.L. Radiographic and endoscopic diagnosis and treatment of enterocutaneous fistulas. Clin. Colon Rectal Surg. 2010;23:149–160. doi: 10.1055/s-0030-1262982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Parada Villavicencio C., Adam S.Z., Nikolaidis P., Yaghmai V., Miller F.H. Imaging of the Urachus: Anomalies, Complications, and Mimics. Radiographics. 2016;36:2049–2063. doi: 10.1148/rg.2016160062. [DOI] [PubMed] [Google Scholar]
- 18.Luo X., Lin J., Du L., Wu R., Li Z. Ultrasound findings of urachal anomalies. A series of interesting cases. Med. Ultrason. 2019;21:294–298. doi: 10.11152/mu-1878. [DOI] [PubMed] [Google Scholar]
- 19.Tublin M., Nelson J., Borhani A., Furlan A., Heller M.T., Squires J. Urachal Anomalies, Imaging in Urology. Elsevier; Amsterdam, The Netherlands: 2018. pp. 204–205. [DOI] [Google Scholar]
- 20.Yang J.D., Hwang H.P., Kim J.H., Rodríguez-Vázquez J.F., Abe S., Murakami G., Cho B.H. Development of the rectus abdominis and its sheath in the human foetus. Yonsei Med. J. 2012;53:1028–1035. doi: 10.3349/ymj.2012.53.5.1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lopes R.I., Tavares A., Srougi M., Dénes F.T. 27 years of experience with the comprehensive surgical treatment of prune belly syndrome. J. Pediatr. Urol. 2015;11:276-e1. doi: 10.1016/j.jpurol.2015.05.018. [DOI] [PubMed] [Google Scholar]
- 22.Jiddane M., Gastaut J.L., Pellissier J.F., Pouget J., Serratrice G., Salamon G. CT of primary muscle diseases. AJNR Am. J. Neuroradiol. 1983;4:773–776. [PMC free article] [PubMed] [Google Scholar]
- 23.Kim H.K., Laor T., Horn P.S., Racadio J.M., Wong B., Dardzinski B.J. T2 mapping in Duchenne muscular dystrophy: Distribution of disease activity and correlation with clinical assessments. Radiology. 2010;255:899–908. doi: 10.1148/radiol.10091547. Erratum in Radiology 2010, 256, 1016. [DOI] [PubMed] [Google Scholar]
- 24.Gregorio-Hernández R., Sanz-López E., Hoyo A.A., Manrique-Martín G., De-Agustín J.C., Sánchez-Luna M. A Rare Complex Case of Congenital Umbilical Arteriovenous Malformation and Review of Literature. AJP Rep. 2016;6:e216–e221. doi: 10.1055/s-0036-1584239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Aymard A., Bisdorf A., Saint-Maurice J.P., Labeyrie M.A., Houdart E. Malformations arterio-veineuses de l’abdomen et du pelvis: Diagnostic et indications thérapeutiques [Abdomino-pelvic arteriovenous malformations: Clinical presentation and management] Presse Med. 2019;48:411–418. doi: 10.1016/j.lpm.2019.03.014. (In French) [DOI] [PubMed] [Google Scholar]
- 26.Aagaard J., Jensen L.I., Sørensen T.I., Christensen U., Burcharth F. Recanalized umbilical vein in portal hypertension. AJR Am. J. Roentgenol. 1982;139:1107–1110. doi: 10.2214/ajr.139.6.1107. [DOI] [PubMed] [Google Scholar]
- 27.Giambelluca D., Caruana G., Cannella R., Picone D., Midiri M. The “caput medusae” sign in portal hypertension. Abdom. Radiol. 2018;43:2535–2536. doi: 10.1007/s00261-018-1493-4. [DOI] [PubMed] [Google Scholar]
- 28.Adachi Y., Yano S. Caput Medusae-like Venous Dilatation in Lung Cancer. Intern. Med. 2019;58:3341–3342. doi: 10.2169/internalmedicine.2577-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Philips C.A., Arora A., Shetty R., Kasana V. A Comprehensive Review of Portosystemic Collaterals in Cirrhosis: Historical Aspects, Anatomy, and Classifications. Int. J. Hepatol. 2016;2016:6170243. doi: 10.1155/2016/6170243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hasslinger C.I., Allison C.F., Barker J.J., Muns E.E., Mackenzie D.C. Woman With a Groin Mass. Ann. Emerg. Med. 2018;72:e107–e108. doi: 10.1016/j.annemergmed.2018.04.028. [DOI] [PubMed] [Google Scholar]
- 31.Madhusudhan K.S., Venkatesh H.A., Gamanagatti S., Garg P., Srivastava D.N. Interventional Radiology in the Management of Visceral Artery Pseudoaneurysms: A Review of Techniques and Embolic Materials. Korean J. Radiol. 2016;17:351–363. doi: 10.3348/kjr.2016.17.3.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Park S.Y., Ahn S.K., Kim H.Y., Shin J.Y., Min S. Referred pain in right arm from abdominal wall pseudoaneurysm. Korean J. Pain. 2013;26:191–194. doi: 10.3344/kjp.2013.26.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Chae S.Y., Park C., Kim J.K., Kim H.O., Lee B.C. Ultrasound-Guided Percutaneous Thrombin Injection of Femoral Artery Pseudoaneurysms Caused by Vascular Access. Taehan Yongsang Uihakhoe Chi. 2021;82:589–599. doi: 10.3348/jksr.2020.0113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Stillman K., Kellar J. Rectus sheath hematoma: An unfortunate consequence of novel anticoagulants. West. J. Emerg. Med. 2015;16:420–421. doi: 10.5811/westjem.2015.2.25631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Contrella B.N., Park A.W., Wilkins L.R., Sheeran D., Hassinger T.E., Angle J.F. Spontaneous Rectus Sheath Hematoma: Factors Predictive of Conservative Management Failure. J. Vasc. Interv. Radiol. 2020;31:323–330. doi: 10.1016/j.jvir.2019.06.009. [DOI] [PubMed] [Google Scholar]
- 36.Shikhman A., Tuma F. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. [(accessed on 22 November 2022)]. Abdominal Hematoma. Available online: https://www.ncbi.nlm.nih.gov/books/NBK519551/ [PubMed] [Google Scholar]
- 37.Leyva A., Tran T., Cibulas A.T., Warden D., IV, Danger F.J., Scherer K., Wasyliw C. Filler Migration and Granuloma Formation After Gluteal Augmentation with Free-silicone Injections. Cureus. 2018;10:e3294. doi: 10.7759/cureus.3294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wosnitzer B., Mirtcheva R. Silicone granulomas following free silicone gluteal augmentation. Radiol. Case Rep. 2015;6:491. doi: 10.2484/rcr.v6i1.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wong K.T., Lee P.S., Chan Y.L., Chow L.T. Paraffinoma in anterior abdominal wall mimicking liposarcoma. Br. J. Radiol. 2003;76:264–267. doi: 10.1259/bjr/31110098. [DOI] [PubMed] [Google Scholar]
- 40.Pasternack F.R., Fox L.P., Engler D.E. Silicone granulomas treated with etanercept. Arch. Dermatol. 2005;141:13–15. doi: 10.1001/archderm.141.1.13. [DOI] [PubMed] [Google Scholar]
- 41.Kamaya A., Federle M.P., Desser T.S. Imaging manifestations of abdominal fat necrosis and its mimics. Radiographics. 2011;31:2021–2034. doi: 10.1148/rg.317115046. [DOI] [PubMed] [Google Scholar]
- 42.Shiba M., Kitazawa T. Progressive insulin-derived amyloidosis in a patient with type 2 diabetes. Case Rep. Plast. Surg. Hand Surg. 2016;3:73–76. doi: 10.1080/23320885.2016.1247650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Iwaya K., Zako T., Fukunaga J., Sörgjerd K.M., Ogata K., Kogure K., Kosano H., Noritake M., Maeda M., Ando Y., et al. Toxicity of insulin-derived amyloidosis: A case report. BMC Endocr. Disord. 2019;19:61. doi: 10.1186/s12902-019-0385-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Valenzuela A., Chung L., Casciola-Rosen L., Fiorentino D. Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol. 2014;150:724–729. doi: 10.1001/jamadermatol.2013.10416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Traineau H., Aggarwal R., Monfort J.B., Senet P., Oddis C.V., Chizzolini C., Barbaud A., Francès C., Arnaud L., Chasset F. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature. J. Am. Acad. Dermatol. 2020;82:317–325. doi: 10.1016/j.jaad.2019.07.006. [DOI] [PubMed] [Google Scholar]
- 46.Brancatelli G., Vilgrain V., Zappa M., Lagalla R. Case 80: Splenosis. Radiology. 2005;234:728–732. doi: 10.1148/radiol.2343030695. [DOI] [PubMed] [Google Scholar]
- 47.Vernuccio F., Dimarco M., Porrello G., Cannella R., Cusmà S., Midiri M., Brancatelli G. Abdominal splenosis and its differential diagnoses: What the radiologist needs to know. Curr. Probl. Diagn. Radiol. 2021;50:229–235. doi: 10.1067/j.cpradiol.2020.04.012. [DOI] [PubMed] [Google Scholar]
- 48.Papakonstantinou E., Kalles V., Papapanagiotou I., Piperos T., Karakaxas D., Bonatsos V., Tsoumakas K., Orfanos F., Mariolis-Sapsakos T. Subcutaneous splenosis of the abdominal wall: Report of a case and review of the literature. Case Rep. Surg. 2013;2013:454321. doi: 10.1155/2013/454321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rizzo S., Monfardini L., Belmonte M., Rocco B., Belloni M. Benign splenosis mimicking peritoneal seeding in a bladder cancer patient: A case report. Cases J. 2009;2:8982. doi: 10.4076/1757-1626-2-8982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Hensen J.-H.J., Van Breda Vriesman A.C., Puylaert J.B.C.M. Abdominal Wall Endometriosis: Clinical Presentation and Imaging Features with Emphasis on Sonography. Am. J. Roentgenol. 2006;186:616–620. doi: 10.2214/AJR.04.1619. [DOI] [PubMed] [Google Scholar]
- 51.Khamechian T., Alizargar J., Mazoochi T. 5-Year data analysis of patients following abdominal wall endometrioma surgery. BMC Women’s Health. 2014;14:151. doi: 10.1186/s12905-014-0151-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Zhang P., Sun Y., Zhang C., Yang Y., Zhang L., Wang N., Xu H. Cesarean scar endometriosis: Presentation of 198 cases and literature review. BMC Women’s Health. 2019;19:14. doi: 10.1186/s12905-019-0711-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Chamié L.P., Ribeiro D.M.F.R., Tiferes D.A., de Macedo Neto A.C., Serafini P.C. Atypical Sites of Deeply Infiltrative Endometriosis: Clinical Characteristics and Imaging Findings. RadioGraphics. 2018;38:309–328. doi: 10.1148/rg.2018170093. [DOI] [PubMed] [Google Scholar]
- 54.Ahn S.E., Park S.J., Moon S.K., Lee D.H., Lim J.W. Sonography of Abdominal Wall Masses and Masslike Lesions: Correlation With Computed Tomography and Magnetic Resonance Imaging. J. Ultrasound Med. 2016;35:189–208. doi: 10.7863/ultra.15.03027. [DOI] [PubMed] [Google Scholar]
- 55.Yarmish G., Sala E., Goldman D.A., Lakhman Y., Soslow R.A., Hricak H., Gardner G.J., Vargas H.A. Abdominal wall endometriosis: Differentiation from other masses using CT features. Abdom. Radiol. 2017;42:1517–1523. doi: 10.1007/s00261-016-0998-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Busard M.P.H., Mijatovic V., van Kuijk C., Hompes P.G.A., van Waesberghe J.H.T.M. Appearance of abdominal wall endometriosis on MR imaging. Eur. Radiol. 2010;20:1267–1276. doi: 10.1007/s00330-009-1658-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Carsote M., Terzea D.C., Valea A., Gheorghisan-Galateanu A.A. Abdominal wall endometriosis (a narrative review) Int. J. Med. Sci. 2020;17:536–542. doi: 10.7150/ijms.38679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Rindos N.B., Mansuria S. Diagnosis and Management of Abdominal Wall Endometriosis: A Systematic Review and Clinical Recommendations. Obstet. Gynecol. Surv. 2017;72:116–122. doi: 10.1097/OGX.0000000000000399. [DOI] [PubMed] [Google Scholar]
- 59.Limperg T., Chaves K., Jesse N., Zhao Z., Yunker A. Ultrasound Visceral Slide Assessment to Evaluate for Intra-abdominal Adhesions in Patients Undergoing Abdominal Surgery—A Systematic Review and Meta-analysis. J. Minim. Invasive Gynecol. 2021;28:1993–2003.e10. doi: 10.1016/j.jmig.2021.07.002. [DOI] [PubMed] [Google Scholar]
- 60.Gerner-Rasmussen J., Donatsky A.M., Bjerrum F. The role of non-invasive imaging techniques in detecting intra-abdominal adhesions: A systematic review. Langenbeck’s Arch. Surg. 2019;404:653–661. doi: 10.1007/s00423-018-1732-8. [DOI] [PubMed] [Google Scholar]
- 61.Buhmann-Kirchhoff S., Lang R., Kirchhoff C., Steitz H.O., Jauch K.W., Reiser M., Lienemann A. Functional cine MR imaging for the detection and mapping of intraabdominal adhesions: Method and surgical correlation. Eur. Radiol. 2008;18:1215–1223. doi: 10.1007/s00330-008-0881-5. [DOI] [PubMed] [Google Scholar]
- 62.Ten Broek R.P., Issa Y., van Santbrink E.J., Bouvy N.D., Kruitwagen R.F., Jeekel J., Bakkum E.A., Rovers M.M., van Goor H. Burden of adhesions in abdominal and pelvic surgery: Systematic review and met-analysis. BMJ (Clin. Res. Ed.) 2013;347:f5588. doi: 10.1136/bmj.f5588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Loftus T.J., Morrow M.L., Lottenberg L., Rosenthal M.D., Croft C.A., Smith R.S., Moore F.A., Brakenridge S.C., Borrego R., Efron P.A., et al. The Impact of Prior Laparotomy and Intra-abdominal Adhesions on Bowel and Mesenteric Injury Following Blunt Abdominal Trauma. World J. Surg. 2019;43:457–465. doi: 10.1007/s00268-018-4792-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Stuparich M.A., Ecker A.M., Lee T.T. Lysis of Anterior Abdominal Wall Adhesions: A Systematic Approach. J. Minim. Invasive Gynecol. 2015;22:S3. doi: 10.1016/j.jmig.2015.08.015. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.